Crossmark

Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma—a retrospective study from the BSBMT (BEAM versus LEAM)

Crossref DOI link: https://doi.org/10.1038/s41409-020-01071-2

Published Online: 2020-09-29

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kelsey, Philippa https://orcid.org/0000-0001-7486-3552
Pearce, Rachel

Perry, Julia

Kirkland, Keiren

Paul, Ruth

Lambert, Jonathan

Peniket, Andy

Malladi, Ram

Snowden, John A. https://orcid.org/0000-0001-6819-3476
Morley, Nick
License Information

Text and Data Mining valid from 2020-09-29

Version of Record valid from 2020-09-29
More Information

Article History

Received: 10 March 2020

Revised: 8 September 2020

Accepted: 21 September 2020

First Online: 29 September 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below